Note 5 - Other Assets (Details Textual) - CAD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | 13 Months Ended | ||
---|---|---|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2018 |
Feb. 28, 2017 |
Feb. 29, 2016 |
Mar. 31, 2017 |
|
Statement Line Items [Line Items] | |||||
Research and development expense | $ 426 | $ 15,669 | $ 7,227 | $ 7,566 | $ 7,653 |
Other current assets | 104 | ||||
Krill oil [member] | |||||
Statement Line Items [Line Items] | |||||
Purchase of other assets | 970 | ||||
Research and development expense | 259 | ||||
Other assets damaged and received credit | 52 | ||||
Other assets | 659 | ||||
Other current assets | $ 104 |
X | ||||||||||
- Definition The other assets damaged and credits received. No definition available.
|
X | ||||||||||
- Definition The amount of other assets purchased. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of assets that the entity does not separately disclose in the same statement or note. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|